Clinical Trial: Cathelicidin LL-37 Relation to Potentially Malignant Lesions

U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT06219330) titled 'Cathelicidin LL-37 Relation to Potentially Malignant Lesions' on Jan. 2.

Brief Summary: LL-37 appears to have a potential role in potentially malignant lesions (OLP & leukoplakia). The remarkable diagnostic accuracy of salivary LL-37 in differentiating potentially malignant lesion and healthy control could confirm its utilization as an innovative marker to early diagnose potentially malignant lesions. Salivary LL-37 being non-invasive accurate marker could be as a chair-side diagnostic method that detect potentially malignant lesions.

Study Type: Observational

Condition: Oral Potentially Malignant Lesions

Recruitment Status: Comp...